| Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors D Quigley, JJ Alumkal, AW Wyatt, V Kothari, A Foye, P Lloyd, R Aggarwal, ... Cancer discovery 7 (9), 999-1005, 2017 | 259 | 2017 |
| Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer WS Chen, R Aggarwal, L Zhang, SG Zhao, GV Thomas, TM Beer, ... European urology 76 (5), 562-571, 2019 | 123 | 2019 |
| Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance JJ Alumkal, D Sun, E Lu, TM Beer, GV Thomas, E Latour, R Aggarwal, ... Proceedings of the National Academy of Sciences 117 (22), 12315-12323, 2020 | 98 | 2020 |
| When to stop eculizumab in complement-mediated thrombotic microangiopathies SR Olson, E Lu, E Sulpizio, JJ Shatzel, JF Rueda, TG DeLoughery American Journal of Nephrology 48 (2), 96-107, 2018 | 58 | 2018 |
| The safety of low-molecular-weight heparin during and after pregnancy E Lu, JJ Shatzel, J Salati, TG DeLoughery Obstetrical & gynecological survey 72 (12), 721-729, 2017 | 24 | 2017 |
| What constitutes an “unmet medical need” in oncology? An empirical evaluation of author usage in the biomedical literature E Lu, J Shatzel, F Shin, V Prasad Seminars in oncology 44 (1), 8-12, 2017 | 20 | 2017 |
| The role of Vldlr in intraretinal angiogenesis in mice C Xia, E Lu, H Liu, X Du, B Beutler, X Gong Investigative Ophthalmology & Visual Science 52 (9), 6572-6579, 2011 | 20 | 2011 |
| West Coast Prostate Cancer Dream Team. Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer WS Chen, R Aggarwal, L Zhang, SG Zhao, GV Thomas, TM Beer, ... Eur. Urol 76, 562-571, 2019 | 16 | 2019 |
| Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing E Lu, KE Hatchell, SM Nielsen, ED Esplin, K Ouyang, K Nykamp, ... Cancer 128 (4), 675-684, 2022 | 15 | 2022 |
| Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization C Xia, E Lu, J Zeng, X Gong PLoS One 8 (9), e75186, 2013 | 14 | 2013 |
| Association between sites of metastasis and outcomes with immune checkpoint inhibitors in advanced urothelial carcinoma D Makrakis, R Talukder, GI Lin, LN Diamantopoulos, S Dawsey, S Gupta, ... Clinical genitourinary cancer 20 (5), e440-e452, 2022 | 11 | 2022 |
| Epirubicin and ifosfamide with preoperative radiation for high-risk soft tissue sarcomas E Lu, KS Perlewitz, JB Hayden, AY Hung, YC Doung, LE Davis, ... Annals of surgical oncology 25, 920-927, 2018 | 11 | 2018 |
| Copy number loss of 17q22 is associated with enzalutamide resistance and poor prognosis in metastatic castration-resistant prostate cancer X Guan, D Sun, E Lu, JA Urrutia, RE Reiter, M Rettig, CP Evans, P Lara Jr, ... Clinical Cancer Research 26 (17), 4616-4624, 2020 | 10 | 2020 |
| DNA repair gene alterations and PARP inhibitor response in patients with metastatic castration-resistant prostate cancer E Lu, GV Thomas, Y Chen, AW Wyatt, P Lloyd, J Youngren, D Quigley, ... Journal of the National Comprehensive Cancer Network 16 (8), 933-937, 2018 | 10 | 2018 |
| The evolving landscape of antibody–drug conjugates for urothelial carcinoma M Abel, A Burkenroad, A Sun, E Lu, D Stefanoudakis, A Drakaki Clinical Genitourinary Cancer 19 (3), 183-193, 2021 | 9 | 2021 |
| Treatment rechallenge with immune checkpoint inhibitors in advanced urothelial carcinoma D Makrakis, DR Bakaloudi, R Talukder, GI Lin, LN Diamantopoulos, ... Clinical genitourinary cancer 21 (2), 286-294, 2023 | 8 | 2023 |
| Feasibility of treating adults with Ewing or Ewing‐like sarcoma with interval‐compressed vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide and etoposide E Lu, CW Ryan, S Bassale, JY Lim, LE Davis The Oncologist 25 (2), 150-155, 2020 | 8 | 2020 |
| Association of the time to immune checkpoint inhibitor (ICI) initiation and outcomes with second line ICI in patients with advanced urothelial carcinoma R Talukder, D Makrakis, GI Lin, LN Diamantopoulos, S Dawsey, S Gupta, ... Clinical genitourinary cancer 20 (6), 558-567, 2022 | 6 | 2022 |
| Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma S Zavoshi, E Lu, PC Boutros, L Zhang, A Harari, KE Hatchell, SM Nielsen, ... Urology 176, 106-114, 2023 | 2 | 2023 |
| Temporal Associations of Plasma Levels of the Secreted Phospholipase A2 Family and Mortality in Severe COVID-19 E Lu, A Hara, S Sun, B Hallmark, JM Snider, MC Seeds, JC Watkins, ... medRxiv, 2022.11. 21.22282595, 2022 | 1 | 2022 |
Joseph ShatzelOregon Health & Science UniversityAdresse e-mail validée de ohsu.edu
